Evidence map›Paper›PMID 30725397›Full record

Observational studyAIDS and behavior2019

The Longitudinal Effects of Non-injection Substance Use on Sustained HIV Viral Load Undetectability Among MSM and Heterosexual Men in Brazil and Thailand: The Role of ART Adherence and Depressive Symptoms (HPTN 063).

Kiyomi Tsuyuki, Steven J Shoptaw, Yusuf Ransome, Gordon Chau, Carlos E Rodriguez-Diaz, Ruth K Friedman, Kriengkrai Srithanaviboonchai, Sue Li, Matthew J Mimiaga, Kenneth H Mayer and 1 more

Abstract readObservational Study
In one paragraph

Observational study in AIDS and behavior, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Overamped: Stimulant Use and HIV Pathogenesis.Current HIV/AIDS reports · 2023
    Review
  8. Article
  9. Article
  10. HIV and Substance Use in Latin America: A Scoping Review.International journal of environmental research and public health · 2022
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kiyomi TsuyukiDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego (UCSD), 9500 Gilman Drive, MC 0507, La Jolla, San Diego, CA, 92093-0507, USA. ktsuyuki@gmail.com.ORCID http://orcid.org/0000-0002-9141-1395
Steven J ShoptawDavid Geffen School of Medicine, Department of Family Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
Yusuf RansomeHarvard T.H. Chan School of Public Health, Boston, MA, USA.
Gordon ChauStatistical Center for HIV/AIDS Research and Prevention (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Carlos E Rodriguez-DiazUniversity of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico.
Ruth K FriedmanInstituto de Pesquisa Clinica Evandro Chagas, Rio de Janeiro, Brazil.
Kriengkrai SrithanaviboonchaiFaculty of Medicine, Chiang Mai University, Muang District, Chiang Mai, Thailand.
Sue LiStatistical Center for HIV/AIDS Research and Prevention (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Matthew J MimiagaCenter for Health Equity Research, Brown University, Providence, RI, USA.
Kenneth H MayerThe Fenway Institute, Fenway Health, Boston, MA, USA.
Steven A SafrenDepartment of Psychology, University of Miami, Coral Gables, FL, USA.

Funding

LOC: HIV Prevention Trials NetworkUM1AI068619 · NIAID · FAMILY HEALTH INTERNATIONAL · PI MYRON Scott COHEN, Sinead Delany-Moretlwe · 2011 to 2026
$779.5M
SDMC: HPTN 084 Pregnancy SupplementUM1AI068617 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Elizabeth Renata Brown, Deborah J Donnell · 2011 to 2026
$204.9M
Harvard Medical School Vaccine Clinical Trials UnitUM1AI069412 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Lindsey Robert Baden, Daniel R. Kuritzkes · 2012 to 2026
$57.2M
UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RAPHAEL J LANDOVITZ · 1997 to 2026
$53.5M
UCLA AIDS Prevention and Treatment Clinical Trials UnitUM1AI069424 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Judith S. Currier, RAPHAEL J LANDOVITZ · 2012 to 2026
$51.8M
UCLA AIDS Prevention and Treatment Clinical Trials UnitU01AI069424 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CURRIER, JUDITH S. · 2007 to 2011
$13.9M
Training Program in Substance Use, HIV and Related InfectionsT32DA023356 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Natasha Martin, Steffanie A Strathdee · 2007 to 2026
$7.8M
Harvard Medical School Vaccine Clinical Trials UnitU01AI069412 · NIAID · HARVARD MEDICAL SCHOOL · PI DOLIN, RAPHAEL · 2007 to 2011
$5.4M
University of Puerto Rico Mentoring Institute for HIV Mental Health ResearchR25MH083617 · NIMH · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI ZORRILLA, CARMEN D · 2008 to 2020
$3.7M
The Brown Initiative in HIV and AIDS Clinical Research for Minority CommunitiesR25MH083620 · NIMH · MIRIAM HOSPITAL · PI NUNN, AMY STEWART · 2008 to 2025
$3.7M
The Impact of Environmental and Physiological Factors on Sexual Assault and HIVR01HD077891 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STOCKMAN, JAMILA KINSHASA · 2013 to 2017
$2.4M
SALUD: Syndemic Alcohol Use Disorders, Violence, and HIV/STI in Young Latino MenK01AA025009 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TSUYUKI, KIYOMI · 2017 to 2021
$939k
Eunice Kennedy Shriver National Institute of Child Health and Human Development R01 HD077891-04S1NIAAA NIH HHS K01 AA025009NIAAA NIH HHS K01AA025009NIAID NIH HHS U01 AI069412NIAID NIH HHS U01 AI069424NIAID NIH HHS UM1 AI068617NIAID NIH HHS UM1 AI068619NIAID NIH HHS UM1 AI069412NIAID NIH HHS UM1 AI069424NICHD NIH HHS R01 HD077891NIDA NIH HHS 9K24DA040489NIDA NIH HHS K24 DA040489NIDA NIH HHS T32 DA023356NIMHD NIH HHS L60 MD011184NIMHD NIH HHS L60MD011184NIMH NIH HHS K01 MH111374NIMH NIH HHS K01MH111374NIMH NIH HHS P30 MH058107NIMH NIH HHS R25 MH083617NIMH NIH HHS R25 MH083620
6 · The paper itself

Abstract

The effect of non-injection substance use on HIV viral load (VL) is understudied in international settings. Data are from HPTN063, a longitudinal observational study of HIV-infected individuals in Brazil, Thailand, and Zambia, with focus on men with VL data (Brazil = 146; Thailand = 159). Generalized linear mixed models (GLMM) assessed whether non-injection substance use (stimulants, cannabis, alcohol, polysubstance) was associated with VL undetectability. ART adherence and depressive symptoms were examined as mediators of the association. In Thailand, substance use was not significantly associated with VL undetectability or ART adherence, but alcohol misuse among MSM was associated with increased odds of depression (AOR = 2.75; 95% CI 1.20, 6.32, p = 0.02). In Brazil, alcohol misuse by MSM was associated with decreased odds of undetectable VL (AOR = 0.34; 95% CI 0.13, 0.92, p = 0.03). Polysubstance use by heterosexual men in Brazil was associated with decreased odds of ART adherence (AOR = 0.25; 95% CI 0.08, 0.78, p = 0.02). VL suppression appears attainable among non-injection substance users. Substance use interventions among HIV-positive men should address depression, adherence, and VL undetectability.

Indexed as

Viral LoadAdultAnti-HIV AgentsBrazilDepressionDrug MonitoringDrug UsersFemaleHeterosexualityHIV-1HIV InfectionsHomosexuality, MaleHumansLongitudinal StudiesMaleMedication AdherenceAnti-HIV AgentsAdherenceDepressionHIVSubstance useUndetectable viral load

Identifiers

PMID30725397
PMCPMC6414080

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.